These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3730770)

  • 1. Regression of osteoblastic metastases from carcinoma of the prostate following therapy with tamoxifen.
    Amin R
    Br J Radiol; 1986 Jul; 59(703):703-4. PubMed ID: 3730770
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged hypocalcemia after zoledronic acid in a patient with metastatic prostate carcinoma: did zoledronic acid trigger osteoblastic activity and avid calcium uptake?
    Ho JW; Sundar S
    Clin Genitourin Cancer; 2012 Mar; 10(1):50-3. PubMed ID: 22245101
    [No Abstract]   [Full Text] [Related]  

  • 3. Relevance of a new rat model of osteoblastic metastases from prostate carcinoma for preclinical studies using zoledronic acid.
    Lamoureux F; Ory B; Battaglia S; Pilet P; Heymann MF; Gouin F; Duteille F; Heymann D; Redini F
    Int J Cancer; 2008 Feb; 122(4):751-60. PubMed ID: 17960623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disappearance of osteoblastic metastases in prostatic carcinoma following estramustine therapy.
    Catane R; Kaufman J; Mittelman A; Murphy GP
    JAMA; 1977 Jun; 237(23):2471. PubMed ID: 576957
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of breast cancer with multiple bone metastases effectively treated with UFT and tamoxifen].
    Endo F; Ishii T; Kito T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):851-4. PubMed ID: 2496670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biphosphonates in the treatment of bone metastasis of prostatic cancer].
    Paule B; Cicco A
    Prog Urol; 2001 Dec; 11(6):1205-12. PubMed ID: 11859653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modification of bone metastases of prostatic carcinoma using estrogens. Roentgenological follow-up study].
    Ludvik W; Riedl P; Zaunbauer W
    Z Urol Nephrol; 1974 Mar; 67(3):165-9. PubMed ID: 4849197
    [No Abstract]   [Full Text] [Related]  

  • 8. Osteoblastic response to successful treatment of metastatic cancer of the prostate.
    Pollen JJ; Shlaer WJ
    AJR Am J Roentgenol; 1979 Jun; 132(6):927-31. PubMed ID: 108971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms in endocrine therapy of bone metastases.
    Stoll BA
    J R Soc Med; 1985; 78 Suppl 9(Suppl 9):11-4. PubMed ID: 4045912
    [No Abstract]   [Full Text] [Related]  

  • 10. Current trials using bone-targeting agents in prostate cancer.
    Tu SM; Lin SH
    Cancer J; 2008; 14(1):35-9. PubMed ID: 18303481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semilunar osteoblastic metastases in breast carcinoma. A new radiological sign.
    Cochrane LB; Heselson NG; Freson M
    J Belge Radiol; 1989 Dec; 72(6):497-500. PubMed ID: 2559915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysis of osteoblastic lesions in prostatic cancer: a sign of progression.
    Pollen JJ; Reznek RH; Talner LB
    AJR Am J Roentgenol; 1984 Jun; 142(6):1175-9. PubMed ID: 6609604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate stimulation of osteoblasts and osteoblastic metastasis as a mechanism of hypocalcaemia.
    Ho JW
    Med Hypotheses; 2012 Mar; 78(3):377-9. PubMed ID: 22206806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management for bone metastasis of prostate cancer].
    Kamoto T
    Gan To Kagaku Ryoho; 2012 Aug; 39(8):1178-82. PubMed ID: 22902440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiodiagnosis of metastases from prostatic carcinoma].
    Jewdokimowa WM; Perelmann WM
    Radiol Diagn (Berl); 1967; 8(1):103-14. PubMed ID: 6078403
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is skeletal alkaline phosphatase a valid staging marker in detection of osteoblastic skeletal metastases of prostate carcinoma?].
    Wirtz DC; Wolff JM; Ittel TH; Jakse G; Niethard FU
    Z Orthop Ihre Grenzgeb; 1998; 136(3):255-9. PubMed ID: 9736988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer.
    Miwa S; Mizokami A; Keller ET; Taichman R; Zhang J; Namiki M
    Cancer Res; 2005 Oct; 65(19):8818-25. PubMed ID: 16204052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Osteoblastic repair of osteolytic tumor metastases following treatment.
    Elias K
    JAMA; 1975 Jan; 231(2):135. PubMed ID: 162786
    [No Abstract]   [Full Text] [Related]  

  • 19. Osteosclerotic prostatic metastasis.
    Chedgy EC; Niematallah I; Hawary A
    ScientificWorldJournal; 2010 Jul; 10():1330-1. PubMed ID: 20623091
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypocalcemia due to avid calcium uptake by osteoblastic metastases of prostate cancer.
    Szentirmai M; Constantinou C; Rainey JM; Loewenstein JE
    West J Med; 1995 Dec; 163(6):577-8. PubMed ID: 8553652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.